All News


All series


All All News

Anne Llewellyn knows how to be a good nurse. For nearly 40 years, she took care of others in the Emergency Department and Respiratory Intensive Care. Her perspective of the health care industry changed a bit after she became the patient. Diagnosed with a central nervous system brain tumor in November 2014, Llewellyn had to become her own advocate, along with the help of her husband.

Cancer in France

By

Having cancer is very much like being in a foreign country.

The combination of Tafinlar (dabrafenib) and Mekinist (trametinib) gained approval from the Food and Drug Administration (FDA) for the treatment of patients with BRAF V600–positive advanced or metastatic non–small cell lung cancer (NSCLC).

Rituxan Hycela (rituximab) was granted approval by the Food and Drug Administration (FDA) for adult patients with previously untreated and relapsed or refractory follicular lymphoma, previously untreated diffuse large B-cell lymphoma (DLBCL) and previously untreated and previously treated chronic lymphocytic leukemia (CLL).